Chapter 11. Micronutrients as Antioxidants

Antioxidants and Disease

Vitamin E

Cardiovascular Disease

Vitamin E reduces the oxidation of LDLs, and it was therefore hypothesized that vitamin E supplements would protect against atherosclerosis. However, there is currently conflicting evidence regarding the antioxidant effect of vitamin E in preventing cardiovascular diseases.[1] Large clinical trials have not consistently found evidence to support the hypothesis that vitamin E supplements protect against atherosclerosis. In fact, in the “Women’s Angiographic Vitamin and Estrogen Study,” postmenopausal women who took 400 international units (264 milligrams) of vitamin E and 500 milligrams of vitamin C twice per day had higher death rates from all causes.[2]

Other studies have not confirmed the association between increased vitamin E intake from supplements and increased mortality. There is more consistent evidence from observational studies that a higher intake of vitamin E from foods is linked to a decreased risk of dying from a heart attack.

Cancer

The large clinical trials that evaluated whether there was a link between vitamin E and cardiovascular disease risk also looked at cancer risk. These trials, the HOPE-TOO Trial and Women’s Health Study, did not find that vitamin E at doses of 400 international units (264 milligrams) per day or 600 international units (396 milligrams) every other day reduced the risk of developing any form of cancer.[3][4] Furthermore, studies have shown that antioxidants play a preventative role in the development of cancer by enhancing the immune system, inhibiting the growth and proliferation of cancerous cells, and preventing oxidative DNA cell damage. A diet high in healthy foods such as fruits, vegetables, and whole grains has been shown to reduce cancer risk.

Eye Conditions

Oxidative stress plays a role in age-related loss of vision, called macular degeneration. Age-related macular degeneration (AMD) primarily occurs in people over age fifty, and it is the progressive loss of central vision resulting from damage to the center of the retina, referred to as the macula. There are two forms of AMD, dry and wet, with wet being the more severe form.

In the dry form, deposits form in the macula; the deposits may or may not directly impair vision, at least in the early stages of the disease. In the wet form, abnormal blood vessel growth in the macula causes vision loss. Clinical trials evaluating the effects of vitamin E supplements on AMD and cataracts (clouding of the lens of an eye) did not consistently observe a decreased risk for either. However, scientists believe vitamin E in combination with other antioxidants such as zinc and copper may slow the progression of macular degeneration in people with early-stage disease.

Dementia

The brain’s high glucose consumption makes it more vulnerable to oxidative stress than other organs. Oxidative stress has been implicated as a major contributing factor to dementia and Alzheimer’s disease. Some studies suggest vitamin E supplements delay the progression of Alzheimer’s disease and cognitive decline, but again, not all of the studies confirm the relationship. A study in 2010 with over five thousand participants published in the July 2010 issue of the Archives of Neurology demonstrated that people with the highest intakes of dietary vitamin E were 25 percent less likely to develop dementia than those with the lowest intakes of vitamin E.[5]

More studies are needed to better assess the dose and dietary requirements of vitamin E and, for that matter, whether other antioxidants lower the risk of dementia, a disease that not only devastates the mind, but also puts a substantial burden on loved ones, caretakers, and society in general.

Vitamin C

Cardiovascular Disease

Vitamin C’s ability to prevent disease has been debated for many years. Overall, higher dietary intakes of vitamin C (via food intake, not supplements) are linked to decreased disease risk. A review of multiple studies published in the April 2009 issue of the Archives of Internal Medicine concludes there is moderate scientific evidence supporting the idea that higher dietary vitamin C intakes are correlated with reduced cardiovascular disease risk, but there is insufficient evidence to conclude that taking vitamin C supplements influences cardiovascular disease risk.[6] Vitamin C levels in the body have been shown to correlate well with fruit and vegetable intake, and higher plasma vitamin C levels are linked to reduced risk of some chronic diseases. In a study involving over twenty thousand participants, people with the highest levels of circulating vitamin C had a 42 percent decreased risk of having a stroke.[7]

Cancer

There is some evidence that a higher vitamin C intake is linked to a reduced risk of cancers of the mouth, throat, esophagus, stomach, colon, and lungs, but not all studies confirm this is true. As with the studies on cardiovascular disease, the reduced risk of cancer is the result of eating foods rich in vitamin C, such as fruits and vegetables, and not from taking vitamin C supplements. In these studies, the specific protective effects of vitamin C cannot be separated from the many other beneficial chemicals in fruits and vegetables.

Immunity

Vitamin C plays several roles in the immune system, and many people increase vitamin C intake either dietarily or from supplements when they have a cold. Many others take vitamin C supplements routinely to prevent colds. Contrary to this popular practice, there is insufficient evidence to support that vitamin C prevents colds. A review of more than fifty years of studies published in 2004 in the Cochrane Database of Systematic Reviews concluded that taking vitamin C routinely does not prevent colds in most people, but it slightly reduces cold severity and duration. Moreover, taking megadoses (up to 4 grams per day) at the onset of a cold provides no benefits.[8]

Gout is a disease caused by elevated circulating levels of uric acid and is characterized by recurrent attacks of tender, hot, and painful joints. There is some evidence that a higher intake of vitamin C reduces the risk of gout.


  1. Garg A, Lee JC-Y. Vitamin E: Where Are We Now in Vascular Diseases? Life. 2022 Feb 18;12(2):310.
  2. Waters DD, et al. Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women: A Randomized Controlled Trial. JAMA. 2002; 288(19), 2432–40. https://jamanetwork.com/journals/jama/fullarticle/195531. Accessed October 5, 2017.
  3. HOPE and HOPE-TOO Trial Investigators. Effects of Long-Term Vitamin E Supplementation on Cardiovascular Events and Cancer. JAMA. 2005; 293, 1338–47. http://jama.ama-assn.org/content/293/11/1338.long., Accessed October 5, 2017.
  4. Lee IM, et al. Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study. JAMA.2005; 294, 56–65. http://jama.ama-assn.org/content/294/1/56.long. Accessed October 5, 2017.
  5. Devore EE, et al. Dietary Antioxidants and Long-Term Risk of Dementia. Arch Neurol. 2010; 67(7), 819–25. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923546/?tool=pubmed. Accessed October 5, 2017.
  6. Mente A, et al. A Systematic Review of the Evidence Supporting a Causal Link between Dietary Factors and Coronary Heart Disease. Arch Intern Med. 2009; 169(7), 659–69. http://archinte.ama-assn.org/cgi/content/full/169/7/659. Accessed October 5, 2017.
  7. Myint PK, et al. Plasma Vitamin C Concentrations Predict Risk of Incident Stroke Over 10 Years in 20,649 Participants of the European Prospective Investigation into Cancer, Norfolk Prospective Population Study. Am J Clin Nutr. 2008; 87(1), 64–69. http://www.ajcn.org/content/87/1/64.long. Accessed September 22, 2017.
  8. Douglas RM, et al. Vitamin C for Preventing and Treating the Common Cold. Cochrane Database of Systematic Reviews. 2004; 4. http://www.ncbi.nlm.nih.gov/pubmed/15495002?dopt=Abstract. Accessed October 5, 2017.

License

Icon for the Creative Commons Attribution-NonCommercial 4.0 International License

Human Nutrition Copyright © 2022 by Luisa Giles and Komal Dhaliwal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, except where otherwise noted.

Share This Book